[{"address1": "321 Harrison Avenue", "address2": "8th Floor", "city": "Boston", "state": "MA", "zip": "02118", "country": "United States", "phone": "781 797 0979", "website": "https://pepgen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 76, "companyOfficers": [{"maxAge": 1, "name": "Dr. James G. McArthur Ph.D.", "age": 62, "title": "President, CEO, Treasurer, Secretary & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 810700, "exercisedValue": 0, "unexercisedValue": 934790}, {"maxAge": 1, "name": "Mr. Noel P. Donnelly M.B.A.", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 604241, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michelle L. Mellion M.D.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 507806, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Gait Ph.D.", "title": "Founder & Scientific Advisory Board Member", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David E. Borah C.F.A., M.B.A.", "title": "Senior VP of IR & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary Beth DeLena J.D.", "age": 56, "title": "General Counsel & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Niels  Svenstrup Ph.D.", "age": 54, "title": "Senior Vice President of Biological Chemistry", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 455150, "exercisedValue": 0, "unexercisedValue": 168610}, {"maxAge": 1, "name": "Ms. Emiko  Bryant", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hayley  Parker Ph.D.", "title": "Senior Vice President of Global Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Afsaneh  Mohebbi Ph.D.", "title": "Senior VP of Portfolio and Program Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.21, "open": 1.24, "dayLow": 1.22, "dayHigh": 1.31, "regularMarketPreviousClose": 1.21, "regularMarketOpen": 1.24, "regularMarketDayLow": 1.22, "regularMarketDayHigh": 1.31, "beta": 1.525, "forwardPE": -0.71549296, "volume": 109940, "regularMarketVolume": 109940, "averageVolume": 300742, "averageVolume10days": 722270, "averageDailyVolume10Day": 722270, "bid": 0.936, "ask": 1.58, "bidSize": 200, "askSize": 200, "marketCap": 41396540, "fiftyTwoWeekLow": 1.16, "fiftyTwoWeekHigh": 19.298, "fiftyDayAverage": 3.2312, "twoHundredDayAverage": 9.39815, "currency": "USD", "enterpriseValue": -78420416, "floatShares": 15483953, "sharesOutstanding": 32595700, "sharesShort": 675579, "sharesShortPriorMonth": 694165, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0207, "heldPercentInsiders": 0.00017999999, "heldPercentInstitutions": 0.96724, "shortRatio": 3.41, "shortPercentOfFloat": 0.0394, "impliedSharesOutstanding": 32595700, "bookValue": 4.218, "priceToBook": 0.30109057, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -87234000, "trailingEps": -2.98, "forwardEps": -2.68, "enterpriseToEbitda": 0.846, "52WeekChange": -0.91219157, "SandP52WeekChange": 0.22903383, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "PEPG", "underlyingSymbol": "PEPG", "shortName": "PepGen Inc.", "longName": "PepGen Inc.", "firstTradeDateEpochUtc": 1651843800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d8556119-2e86-3dba-8e6a-e25559b6dab2", "messageBoardId": "finmb_1677986244", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.27, "targetHighPrice": 20.0, "targetLowPrice": 3.0, "targetMeanPrice": 12.8, "targetMedianPrice": 16.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 138856992, "totalCashPerShare": 4.26, "ebitda": -92726000, "totalDebt": 19040000, "quickRatio": 8.26, "currentRatio": 8.469, "debtToEquity": 13.852, "returnOnAssets": -0.35202998, "returnOnEquity": -0.66257006, "freeCashflow": -52014124, "operatingCashflow": -82321000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]